Verified Nov 2026
Other
·

South San Francisco, California
·
Since 1976
Genentech is a biotechnology corporation headquartered in South San Francisco, California, founded in 1976 as the first biotechnology company. With approximately 12,300 employees and revenue exceeding $10 billion, it operates as an independent subsidiary of the Roche Group. The company discovers, develops, manufactures, and commercializes biopharmaceutical medicines across oncology, immunology, neuroscience, ophthalmology, infectious disease, metabolism, and tissue repair, serving the medical and industrial equipment sectors.
Genentech at a glance
Revenue
$10B+
Est. band
Employees
10,000-50,000
Founded
1976
Headquarters
South San Francisco, California
Import activity
866
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
866
Named foreign suppliers
50
Top origins
Japan · Belgium · Portugal · Taiwan

Shared foreign counterparties do not establish that these companies buy from Genentech.
What this tells a buyer
Genentech received over 87,600 shipments from Japan alone, with major suppliers including Nippon Express, Ajinomoto, and Schott, sourcing materials from 17 countries across Europe, Asia, and the Americas.
The company manufactures monoclonal antibodies, small-molecule medicines, and biologic therapeutics, including targeted antibody treatments for cancer and therapies for progressive neurological conditions.
Genentech invested $750 million in a manufacturing expansion in Hillsboro, Oregon, completed in 2026, and opened a new facility in Holly Springs, North Carolina as part of its capacity growth strategy.
Source: US customs bill-of-lading records and public filings · Last verified Nov 16, 2026
STABILITY SIGNALS
Established & active
50 years in operation (founded 1976).
866 US import shipments on record.
Overview
Genentech is a biotechnology corporation headquartered in South San Francisco, California, founded in 1976 as the first biotechnology company. With approximately 12,300 employees and revenue exceeding $10 billion, it operates as an independent subsidiary of the Roche Group. The company discovers, develops, manufactures, and commercializes biopharmaceutical medicines across oncology, immunology, neuroscience, ophthalmology, infectious disease, metabolism, and tissue repair, serving the medical and industrial equipment sectors.
At a glance
Attribute | Detail |
|---|---|
Founded | 1976 |
Headquarters | South San Francisco, California |
Employees | 10,000-50,000 |
Revenue | $10B+ (estimated) |
What Genentech makes
The company manufactures monoclonal antibodies, small-molecule medicines, and biologic therapeutics, including targeted antibody treatments for cancer and therapies for progressive neurological conditions.
Products and capabilities described on the company's own site include Steel (source: gene.com).
Trade and customs footprint
Genentech received over 87,600 shipments from Japan alone, with major suppliers including Nippon Express, Ajinomoto, and Schott, sourcing materials from 17 countries across Europe, Asia, and the Americas. US customs bill-of-lading records list 866 inbound shipments across 50 foreign suppliers, with top origins including Japan · Belgium · Portugal · Taiwan.
Latest developments
2026-09-28 — Genentech: Press Releases | Monday, Sep 28, 2026 (gene.com)
2026-09-17 — Genentech: Press Releases | Thursday, Sep 17, 2026 (gene.com)
2026-08-24 — Genentech invests $750m in Oregon plant, inks Hanmi deal (bioprocessintl.com)
2026-08-20 — Genentech: Press Releases | Genentech Announces Manufacturing Expansion in Hillsboro, Oregon (gene.com)
2026-08-18 — Genentech: Press Releases | Genentech Marks Topping Out Milestone for New Holly Springs, North Carolina Manufacturing Facility (gene.com)
2026-02-02 — Genentech, SanegeneBio Launch Up-to-$1.7B RNAi Collaboration (genengnews.com)
Facilities
Genentech is headquartered in South San Francisco, California. Public sources also reference these locations:
Hillsboro, Oregon — gene.com
Company details
Genentech invested $750 million in a manufacturing expansion in Hillsboro, Oregon, completed in 2026, and opened a new facility in Holly Springs, North Carolina as part of its capacity growth strategy. Genentech was founded in 1976, has an estimated 10,000-50,000 employees, and is headquartered in South San Francisco, California. On the LightSource stability read it is rated "Established & active": 50 years in operation (founded 1976). 866 US import shipments on record.
Frequently asked questions
What does Genentech do?
Genentech is a biotechnology corporation headquartered in South San Francisco, California, founded in 1976 as the first biotechnology company. With approximately 12,300 employees and revenue exceeding $10 billion, it operates as an independent subsidiary of the Roche Group. The company discovers, develops, manufactures, and commercializes biopharmaceutical medicines across oncology, immunology, neuroscience, ophthalmology, infectious disease, metabolism, and tissue repair, serving the medical and industrial equipment sectors.
Where is Genentech headquartered?
Genentech is headquartered in South San Francisco, California (1 DNA Way, South San Francisco, California, 94080).
When was Genentech founded?
Genentech was founded in 1976.
How big is Genentech?
Genentech has an estimated 10,000-50,000 employees, with revenue in the $10B+ range (estimated).
Does Genentech import from overseas suppliers?
US customs bill-of-lading records show 866 inbound shipments for Genentech, with top origins including Japan · Belgium · Portugal · Taiwan.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
